Drugs / LYC-30937
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02818543 | Mar → Jun 2016 | ulcerative colitis | Lycera Corp. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LYC-30937 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02818543 ↗ |
| Route | Oral | “Orally Administered LYC-30937” NCT02818543 ↗ |